D-0276-2022 Class II Terminated

Recalled by Ascent Pharmaceuticals, Inc. — Central Islip, NY

FDA drug recall D-0276-2022 was initiated by Ascent Pharmaceuticals, Inc. on Nov 19, 2021 and is designated Class II. Reason for recall: Product Mix-up The recall status is terminated (terminated Dec 6, 2023). Affected quantity: 9744 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 15, 2021
Initiation Date
Nov 19, 2021
Termination Date
Dec 6, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9744 bottles

Product description

Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg, 100-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Manufactured by: Ascent Pharmaceuticals, Inc., Central Islip, NY 11722, NDC 31722-997-01.

Reason for recall

Product Mix-up

Distribution pattern

USA Nationwide

Code information

Lot #: 21070817, Exp 6/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0276-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0276-2022. Report a data issue: hello@regdatalab.com.